PharmaLinea Podcast
For a product to stand out in the flooded nutraceutical market, differentiation through clinical substantiation is key; however, many brands view this as a risk due to the high upfront costs and the lack of a guaranteed positive outcome. We discussed the future of clinical trials and how Radicle Science's technology-based platform aims to make them more accessible to everyone with Pelin Wood Thorogood, the company's Co-Founder and Executive Chairwoman. Highlights: 00:00 Introduction 03:43 Radicle Science background 10:20 The need for alternate clinical trials design 12:59 Studies on ingredients vs. finished products 17:53 Radicle Science business model & trial design 21:11 Clinical trial platform & how it works 25:56 Trial range 28:10 Client case study 33:30 Investing in clinicals before going to market 38:15 Using the clinical data in marketing 41:02 Targeting specific subpopulations 48:10 Recognition within the industry 49:00 Justifying the investment 51:25 How marketing and clinical trials will evolve in the future 58:30 What's next for Radicle Science?
10 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de PharmaLinea Podcast!